Positive Results For SciClone
SciClone Pharmaceuticals Inc. (SCLN) reported positive survival data for its melanoma drug treatment trial. The stock price surged 87 cents to close at $3.13.
posted by FC Market News at 10:18 AM
0 Comments:
Post a Comment
<< Home